Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1)

Circulation

Volumn 102, Issue 17, 2000, Pages 2124-2130

  Marra, Diego E ^a   Simoncini, Tommaso ^a   Liao, James K ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aspirin; Cells; Kinases; Muscle, smooth; Proteins

Indexed keywords

CYCLIN DEPENDENT KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; SALICYLATE SODIUM;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

EID: 0034711143     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.17.2124     Document Type: Article

References (38)

1. Cell cycle progression: New therapeutic target for vascular proliferative disease
2. Cancer cell cycles
3. Cell cycle progression and cell growth in mammalian cells
4. Protein kinases and cell cycle control
5. The retinoblastoma protein and cell cycle control
6. E2F and the molecular mechanisms of early cell-cycle control
7. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
8. Cdk inhibitors: On the threshold of checkpoints and development
9. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
10. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
11. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4
12. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
13. p21 Is a universal inhibitor of cyclin kinases
14. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells
15. Growth inhibition of rat glioma cells in vitro and in vivo by aspirin
16. Acetylsalicylic acid, at high concentrations, inhibits vascular smooth muscle cell proliferation
17. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma: The role of constitutive NF-kappa B activity
18. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants
19. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
20. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
21. p53, The cellular gatekeeper for growth and division
22. Vascular smooth muscle cells express a constitutive NF-kappa B-like activity
23. Inhibition of NF-kappa B by sodium salicylate and aspirin
24. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
25. Phosphorylation of the retinoblastoma protein by cdk2
26. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts
27. CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation
28. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells
29. Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells
30. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
31. p27, A novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
32. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage
33. p21 Is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells
34. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
35. Structure, regulation and function of NF-kappa B
36. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
37. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury: Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1
38. Nuclear factor-kappaB activity and arterial response to balloon injury